7 news items
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
ZOM
6 May 24
, and judgments, uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
ZOM
2 May 24
benefiting small animal practices and equine or mixed veterinary practices.The newly patents issued include innovations in the TRUFORMA
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ZOM
1 Apr 24
products that the Company expects to launch during 2024. Guidance for 2024 does not incorporate any positive benefits from acquisitions the Company may
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
ZOM
14 Mar 24
fully utilized in the clinic, veterinarians and their patients will also have the added benefit of results in less than half an hour rather than waiting
Zomedica Provides NYSE American Listing Update
ZOM
13 Mar 24
as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work
byd7d7b7fu0sh2ynxmp
ZOM
12 Mar 24
provides us with an exceptional opportunity to bring awareness to veterinarians about the many ways Zomedica's products and services can benefit them
me0vq373diezfoopi d8pzrk
ZOM
7 Mar 24
be achieved in animal health. Each new indication for this technology not only brings the benefit to new pet patients, but it also expands the market
- Prev
- 1
- Next